Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-03-15 @ 1:31 PM
Study NCT ID:
NCT00673504
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2008-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
Sponsor:
Central European Society for Anticancer Drug Research
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
C-II-004 / 2007-005022-71
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Central European Society for Anticancer Drug Research-EWIV
Old Organization:
Non-Profit Otrganization Oncology